{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T23:09:28Z","timestamp":1790809768680,"version":"4.1.0"},"reference-count":37,"publisher":"Royal Society of Chemistry (RSC)","issue":"17","license":[{"start":{"date-parts":[[2019,7,11]],"date-time":"2019-07-11T00:00:00Z","timestamp":1562803200000},"content-version":"am","delay-in-days":556,"URL":"http:\/\/rsc.li\/journals-terms-of-use"}],"funder":[{"DOI":"10.13039\/501100004962","name":"Conseil R\u00e9gional d'Auvergne","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004962","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["rsc.org"],"crossmark-restriction":true},"short-container-title":["Analyst"],"abstract":"<p>5-Fluorouracil (5-FU) is one of the most widely antineoplastic drugs handled by healthcare professionals.<\/p>","DOI":"10.1039\/c8an00479j","type":"journal-article","created":{"date-parts":[[2018,7,11]],"date-time":"2018-07-11T10:36:16Z","timestamp":1531305376000},"page":"4110-4117","update-policy":"https:\/\/doi.org\/10.1039\/rsc_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Biomonitoring of occupational exposure to 5-FU by assaying \u03b1-fluoro-\u03b2-alanine in urine with a highly sensitive UHPLC-MS\/MS method"],"prefix":"10.1039","volume":"143","author":[{"given":"Alice","family":"Dhersin","sequence":"first","affiliation":[{"name":"Laboratoire de Pharmacologie Clinique et Toxicologie"},{"name":"33076 Bordeaux"},{"name":"France"},{"name":"INSERM U1219"},{"name":"Universit\u00e9 de Bordeaux"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beno\u00eet","family":"Atg\u00e9","sequence":"additional","affiliation":[{"name":"Laboratoire de Pharmacologie Clinique et Toxicologie"},{"name":"33076 Bordeaux"},{"name":"France"},{"name":"INSERM U1219"},{"name":"Universit\u00e9 de Bordeaux"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e9atrice","family":"Martinez","sequence":"additional","affiliation":[{"name":"INSERM U1219"},{"name":"Universit\u00e9 de Bordeaux"},{"name":"33076 Bordeaux"},{"name":"France"},{"name":"Univ. of Bordeaux"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karine","family":"Titier","sequence":"additional","affiliation":[{"name":"Laboratoire de Pharmacologie Clinique et Toxicologie"},{"name":"33076 Bordeaux"},{"name":"France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marine","family":"Rousset","sequence":"additional","affiliation":[{"name":"Laboratoire de Pharmacologie Clinique et Toxicologie"},{"name":"33076 Bordeaux"},{"name":"France"},{"name":"INSERM U1219"},{"name":"Universit\u00e9 de Bordeaux"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Sidatt Cheikh El Moustaph","sequence":"additional","affiliation":[{"name":"Minist\u00e8re de la Sant\u00e9"},{"name":"Nouakchott"},{"name":"Mauritanie"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Verdun-Esquer","sequence":"additional","affiliation":[{"name":"INSERM U1219"},{"name":"Universit\u00e9 de Bordeaux"},{"name":"33076 Bordeaux"},{"name":"France"},{"name":"Service de M\u00e9decine du Travail et de Pathologies Professionnelles"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathieu","family":"Molimard","sequence":"additional","affiliation":[{"name":"Laboratoire de Pharmacologie Clinique et Toxicologie"},{"name":"33076 Bordeaux"},{"name":"France"},{"name":"INSERM U1219"},{"name":"Universit\u00e9 de Bordeaux"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4870-3226","authenticated-orcid":false,"given":"Antoine","family":"Villa","sequence":"additional","affiliation":[{"name":"Consultation de Pathologie Professionnelle"},{"name":"GH Fernand Widal-Lariboisi\u00e8re-Saint Louis"},{"name":"75010 Paris"},{"name":"France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4140-1639","authenticated-orcid":false,"given":"Mireille","family":"Canal-Raffin","sequence":"additional","affiliation":[{"name":"Laboratoire de Pharmacologie Clinique et Toxicologie"},{"name":"33076 Bordeaux"},{"name":"France"},{"name":"INSERM U1219"},{"name":"Universit\u00e9 de Bordeaux"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"292","published-online":{"date-parts":[[2018]]},"reference":[{"key":"C8AN00479J-(cit1)\/*[position()=1]","doi-asserted-by":"crossref","first-page":"E359","DOI":"10.1002\/ijc.29210","volume":"136","author":"Ferlay","year":"2015","journal-title":"Int. J. Cancer"},{"key":"C8AN00479J-(cit2)\/*[position()=1]","volume-title":"Synth\u00e8se. Stat.","author":"Amira","year":"2014","unstructured":"S. Amira , Les risques professionnels par m\u00e9tiers. Enqu\u00eate Sumer, 2010. Direction de l'animation de la recherche, des \u00e9tudes et des statistiques (DARES), Synth\u00e8se. Stat. , 2014 , vol. 5"},{"key":"C8AN00479J-(cit3)\/*[position()=1]","doi-asserted-by":"crossref","first-page":"354","DOI":"10.3322\/canjclin.56.6.354","volume":"56","author":"Connor","year":"2006","journal-title":"CA-Cancer J. Clin."},{"key":"C8AN00479J-(cit4)\/*[position()=1]","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1097\/JOM.0000000000000249","volume":"56","author":"Connor","year":"2014","journal-title":"J. Occup. Environ. Med."},{"key":"C8AN00479J-(cit5)\/*[position()=1]","first-page":"855","volume":"49","author":"Skov","year":"1992","journal-title":"Br. J. Ind. Med."},{"key":"C8AN00479J-(cit6)\/*[position()=1]","volume-title":"NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings","author":"Anonymous","year":"2016","unstructured":"Anonymous , NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings , Centers for Disease Control and Prevention \u2013 National Institute for Occupational Safety and Health , 2016"},{"key":"C8AN00479J-(cit7)\/*[position()=1]","volume-title":"Some Antineoplastic and Immunosuppressive Agents. IARC Monogr Eval Carcinog Risks Hum: IARC","author":"Anonymous","year":"1981","unstructured":"Anonymous , Some Antineoplastic and Immunosuppressive Agents. IARC Monogr Eval Carcinog Risks Hum: IARC , IARC , 1981"},{"key":"C8AN00479J-(cit8)\/*[position()=1]","volume-title":"Overall Evaluations of Carcinogenicity: An Updating of IARC Monographs Volumes 1 to 42","author":"Anonymous","year":"1987","unstructured":"Anonymous , Overall Evaluations of Carcinogenicity: An Updating of IARC Monographs Volumes 1 to 42 , IARC , 1987"},{"key":"C8AN00479J-(cit9)\/*[position()=1]","volume-title":"Some antiviral and antineoplastic drugs, and other pharmaceutical agents","author":"Anonymous","year":"2000","unstructured":"Anonymous , Some antiviral and antineoplastic drugs, and other pharmaceutical agents , IARC , 2000"},{"key":"C8AN00479J-(cit10)\/*[position()=1]","volume-title":"Content and Format of Labeling for Human Prescription Drug and Biological Products; Requirements for Pregnancy and Lactation Labeling","author":"Anonymous","year":"2008","unstructured":"Anonymous , Content and Format of Labeling for Human Prescription Drug and Biological Products; Requirements for Pregnancy and Lactation Labeling , Food and Drug Administration , 2008"},{"key":"C8AN00479J-(cit11)\/*[position()=1]","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1002\/bmc.3684","volume":"30","author":"Fabrizi","year":"2016","journal-title":"Biomed. Chromatogr."},{"key":"C8AN00479J-(cit12)\/*[position()=1]","doi-asserted-by":"crossref","first-page":"215","DOI":"10.2165\/00003088-198916040-00002","volume":"16","author":"Diasio","year":"1989","journal-title":"Clin. Pharmacokinet."},{"key":"C8AN00479J-(cit13)\/*[position()=1]","first-page":"2203","volume":"47","author":"Heggie","year":"1987","journal-title":"Cancer Res."},{"key":"C8AN00479J-(cit14)\/*[position()=1]","first-page":"79","volume":"36","author":"Sessink","year":"1994","journal-title":"J. Occup. Med."},{"key":"C8AN00479J-(cit15)\/*[position()=1]","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1080\/135475098231390","volume":"3","author":"Bos","year":"1998","journal-title":"Biomarkers"},{"key":"C8AN00479J-(cit16)\/*[position()=1]","first-page":"251","volume":"57","author":"Yoshida","year":"2013","journal-title":"Ann. Occup. Hyg."},{"key":"C8AN00479J-(cit17)\/*[position()=1]","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1002\/bmc.559","volume":"20","author":"Rubino","year":"2006","journal-title":"Biomed. Chromatogr."},{"key":"C8AN00479J-(cit18)\/*[position()=1]","doi-asserted-by":"crossref","first-page":"2630","DOI":"10.1016\/j.jchromb.2010.02.011","volume":"878","author":"Ndaw","year":"2010","journal-title":"J. Chromatogr. B: Anal. Technol. Biomed. Life Sci."},{"key":"C8AN00479J-(cit19)\/*[position()=1]","volume-title":"Guideline on bioanalytical method validation","author":"Anonymous","year":"2012","unstructured":"Anonymous , Guideline on bioanalytical method validation , C. f. M. P. f. H. U. (CHMP), European Medicines Agency (EMEA) , 2012"},{"key":"C8AN00479J-(cit20)\/*[position()=1]","volume-title":"FLUOROURACIL injection, for intravenous use Initial U.S. Approval: 1962 \u2013 Revised: 07\/2016 \u2013 Reference ID: 3965252","author":"Anonymous","year":"2016","unstructured":"Anonymous , FLUOROURACIL injection, for intravenous use Initial U.S. Approval: 1962 \u2013 Revised: 07\/2016 \u2013 Reference ID: 3965252 , Food and Drug Administration (FDA) , 2016"},{"key":"C8AN00479J-(cit21)\/*[position()=1]","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1097\/00043764-199706000-00013","volume":"39","author":"Valanis","year":"1997","journal-title":"J. Occup. Environ. Med."},{"key":"C8AN00479J-(cit22)\/*[position()=1]","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1097\/01.ede.0000246827.44093.c1","volume":"18","author":"Fransman","year":"2007","journal-title":"Epidemiology"},{"key":"C8AN00479J-(cit23)\/*[position()=1]","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1002\/ajim.22553","volume":"59","author":"Zhang","year":"2016","journal-title":"Am. J. Ind. Med."},{"key":"C8AN00479J-(cit24)\/*[position()=1]","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1136\/jech.39.2.141","volume":"39","author":"Hemminki","year":"1985","journal-title":"J. Epidemiol. Community Health"},{"key":"C8AN00479J-(cit25)\/*[position()=1]","first-page":"581","volume":"45","author":"McDonald","year":"1988","journal-title":"Br. J. Ind. Med."},{"key":"C8AN00479J-(cit26)\/*[position()=1]","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1177\/216507999304100301","volume":"41","author":"McAbee","year":"1993","journal-title":"AAOHN J."},{"key":"C8AN00479J-(cit27)\/*[position()=1]","doi-asserted-by":"crossref","first-page":"137","DOI":"10.5271\/sjweh.523","volume":"26","author":"Lorente","year":"2000","journal-title":"Scand. J. Work, Environ. Health"},{"key":"C8AN00479J-(cit28)\/*[position()=1]","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1472-6955-9-15","volume":"9","author":"Ratner","year":"2010","journal-title":"BMC Nurs."},{"key":"C8AN00479J-(cit29)\/*[position()=1]","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1056\/NEJM198511073131901","volume":"313","author":"Selevan","year":"1985","journal-title":"N. Engl. J. Med."},{"key":"C8AN00479J-(cit30)\/*[position()=1]","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1111\/j.1547-5069.1987.tb00604.x","volume":"19","author":"Rogers","year":"1987","journal-title":"Image J. Nurs. Sch."},{"key":"C8AN00479J-(cit31)\/*[position()=1]","doi-asserted-by":"crossref","first-page":"102","DOI":"10.5271\/sjweh.1811","volume":"16","author":"Stucker","year":"1990","journal-title":"Scand. J. Work, Environ. Health"},{"key":"C8AN00479J-(cit32)\/*[position()=1]","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1097\/00043764-199908000-00004","volume":"41","author":"Valanis","year":"1999","journal-title":"J. Occup. Environ. Med."},{"issue":"4","key":"C8AN00479J-(cit33)\/*[position()=1]","doi-asserted-by":"crossref","first-page":"327.e1","DOI":"10.1016\/j.ajog.2011.12.030","volume":"206","author":"Lawson","year":"2012","journal-title":"Am. J. Obstet. Gynecol."},{"key":"C8AN00479J-(cit34)\/*[position()=1]","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1191\/1078155205jp155oa","volume":"11","author":"Dranitsaris","year":"2005","journal-title":"J. Oncol. Pharm. Pract."},{"key":"C8AN00479J-(cit35)\/*[position()=1]","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/0140-6736(93)91000-C","volume":"341","author":"Saurel-Cubizolles","year":"1993","journal-title":"Lancet"},{"key":"C8AN00479J-(cit36)\/*[position()=1]","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1097\/00002820-199512000-00003","volume":"18","author":"Shortridge","year":"1995","journal-title":"Cancer Nurs."},{"key":"C8AN00479J-(cit37)\/*[position()=1]","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.jchromb.2017.06.028","volume":"1060","author":"Mathias","year":"2017","journal-title":"J. Chromatogr. B: Anal. Technol. Biomed. Life Sci."}],"container-title":["The Analyst"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/pubs.rsc.org\/en\/content\/articlepdf\/2018\/AN\/C8AN00479J","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T17:52:06Z","timestamp":1782928326000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.rsc.org\/an\/article\/143\/17\/4110-4117\/591474"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"references-count":37,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1039\/c8an00479j","relation":{},"ISSN":["0003-2654","1364-5528"],"issn-type":[{"value":"0003-2654","type":"print"},{"value":"1364-5528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018]]},"assertion":[{"value":"This document is Similarity Check deposited","name":"similarity_check","explanation":{"URL":"https:\/\/www.crossref.org\/services\/similarity-check\/"},"group":{"name":"similarity_check","label":"SIMILARITY CHECK"}},{"value":"Antoine Villa (ORCID)","URL":"http:\/\/orcid.org\/0000-0003-4870-3226","name":"identifier","group":{"name":"author_identifiers","label":"IDENTIFIERS"}},{"value":"Mireille Canal-Raffin (ORCID)","URL":"http:\/\/orcid.org\/0000-0003-4140-1639","name":"identifier","group":{"name":"author_identifiers","label":"IDENTIFIERS"}},{"value":"Single-blind","order":2,"name":"peer_review_method","group":{"name":"peer_review_method","label":"PEER REVIEW METHOD"}},{"value":"Received 15 March 2018; Accepted 29 June 2018; Accepted Manuscript published 11 July 2018; Advance Article published 30 July 2018; Version of Record published 20 August 2018","order":1,"name":"history","group":{"name":"publication_history","label":"PUBLICATION HISTORY"}}]}}